Pyrimidinyl aryl urea derivatives being FGF inhibitors

Details for Australian Patent Application No. 2006326989 (hide)

Owner Novartis AG

Inventors Bold, Guido; Furet, Pascal; Guagnano, Vito

Agent Davies Collison Cave

Pub. Number AU-B-2006326989

PCT Pub. Number WO2007/071752

Priority 60/752,711 21.12.05 US

Filing date 20 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 24 November 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 239/32 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071752 Priority application(s): WO2007/071752

24 November 2011 Application Accepted

  Published as AU-B-2006326989

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326996-Apparatus for continuous pressure massage

2006326984-Fuel composition